Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.64 |
| ▸ | CA2 | P00918 | 15/20 | 0.64 |
| ▸ | CA9 | Q16790 | 13/20 | 0.64 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA7 | P43166 | 4/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA6 | P23280 | 3/20 | 0.64 |
| ▸ | CA5A | P35218 | 3/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28627781 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28358597 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28922483 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL3100937 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL6129804 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL28354945 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336095 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5677448 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL22289152 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 | |
| SCHEMBL39943 | 1.00 | CA1 (0.64) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106865676-A | A kind of sewage water treatment method | 宁波诺丁汉大学 | 2017-06-20 | — | — | CN | disclosed |
| EP-2832730-A1 | MIRABEGRON-CONTAINING PHARMACEUTICAL COMPOSITION | Astellas Pharma Inc. (JP) | 2015-02-04 | — | — | EP | disclosed |
| US-20150031734-A1 | PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRON | ASTELLAS PHARMA INC. (JP) | 2015-01-29 | — | — | US | disclosed |
| CN-102946903-B | High concentration antibody formulations | AMGEN INC | 2014-11-26 | — | — | CN | disclosed |
| CN-102946903-A | High concentration antibody formulations | AMGEN INC | 2013-02-27 | — | — | CN | disclosed |
| US-20120058974-A1 | Composition comprising pesticide and benzotriazole UV absorbers | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-7811605-B2 | Method of formation of shape-retentive aggregates of gel particles and their uses | ULURU INC. (US) | 2010-10-12 | — | — | US | disclosed |
| US-20080063716-A1 | METHOD OF FORMATION OF SHAPE-RETENTIVE AGGREGATES OF GEL PARTICLES AND THEIR USES | ULURU INC. | 2008-03-13 | — | — | US | disclosed |
| CN-101065109-A | Method of formation of shape-retentive aggregates of gel particles and their uses | ULURU INC (US) | 2007-10-31 | — | — | CN | disclosed |
| EP-1814522-A1 | METHOD OF FORMATION OF THE SHAPE-RETENTIVE AGGREGATES OF GEL PARTICLES AND THEIR USES | Uluru Inc. (US) | 2007-08-08 | — | — | EP | disclosed |
| CN-1521201-A | Waterproof ventilated microporous membrane, its preparing method and use | 上海杰事杰新材料股份有限公司 | 2004-08-18 | — | — | CN | disclosed |
| US-6117975-A | AMINO ACID AND NUCLEOTIDE SEQUENCES; FOR THERAPY | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-09-12 | — | — | US | disclosed |
| US-5869257-A | NUCLEIC ACID INDICATOR FOR DETERMINING THE EXPRESSION OF MELANOCORTIN-4 RECEPTORS BY HYBRIDIZATION TO COMPLEMENTARY SEQUENCE; PHYSIOLOGICAL THERAPY INVOLVING ORGANS AND TISSUES EXPRESSING RECEPTOR; DRUG SCREENING | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1999-02-09 | — | — | US | disclosed |
| US-5817787-A | Probes and methods for detecting melanocortin-5 receptor | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-10-06 | — | — | US | disclosed |
| US-5710265-A | GENETIC ENGINEERING; POLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-01-20 | — | — | US | disclosed |
| US-5703220-A | MAY BE USED TO PROVIDE THERAPEUTIC VEHICLES FOR TREATMENT OF PROCESSES INVOLVING FUNCTION OF MELANOCORTIN RECEPTORS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1997-12-30 | — | — | US | disclosed |
| US-5622860-A | GENETIC ENGINEERING | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1997-04-22 | — | — | US | disclosed |
| EP-0000082-B1 | PROCESS FOR IMAGE-WISE MODIFYING THE SURFACE OF AN ETCHABLE SUPPORT AND MATERIAL SUITABLE THEREFOR COMPRISING A COLLOID LAYER CONTAINING POLYMERS WITH OXIME-ESTER GROUPS | AGFA-GEVAERT N.V. (BE) | 1982-07-21 | — | — | EP | disclosed |
| US-4202697-A | Production of etch-resist colloid and material suitable therefor | AGFA-GEVAERT N.V. (BE) | 1980-05-13 | — | — | US | disclosed |
| EP-0000082-A1 | Process for image-wise modifying the surface of an etchable support and material suitable therefor comprising a colloid layer containing polymers with oxime-ester groups | AGFA-GEVAERT N.V. (BE) | 1978-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058974-A1 | Composition comprising pesticide and benzotriazole UV absorbers | DDT, CRY1, PAH | CA1 1176/4885CA2 1381/4885CA9 3100/4885 |
| US-20150031734-A1 | PHARMACEUTICAL COMPOSITION CONTAINING MIRABEGRON | GCGR, GPR119, GLP1R | CA1 4633/4885CA2 3483/4885CA9 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.